www.aging-us.com AGING 2021, Vol. 13, No. 4 Research Paper Chemical composition and pharmacological mechanism of ephedra- glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19) Xiaoling Li1,*, Qin Qiu2,*, Mingyue Li3,*, Haowen Lin4, Shilin Cao5,6, Qu Wang4, Zishi Chen5, Wenhao Jiang5, Wen Zhang7, Yuge Huang8, Hui Luo9, Lianxiang Luo9,10 1Animal Experiment Center of Guangdong Medical University, Zhanjiang 524023, Guangdong, China 2Graduate School of Guangdong Medical University, Zhanjiang 524023, Guangdong, China 3Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA 4The First Clinical College of Guangdong Medical University, Zhanjiang 524023, Guangdong, China 5Group of Sustainable Biochemical Engineering, School of Food Science and Engineering, Foshan University, Foshan 528000, Guangdong, China 6Sustainable Biochemical and Biosynthetic Engineering Center, Foshan Wu-Yuan Biotechnology Co., Ltd., Guangdong Biomedical Industrial Base, Foshan 528000, Guangdong, China 7Aditegen LLC, Jersey, NJ 07310, USA 8Department of Pediatrics, the Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China 9The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, Guangdong, China 10Marine Medical Research Institute of Zhanjiang, Zhanjiang 524023, Guangdong, China *Equal contribution Correspondence to: Lianxiang Luo; email:
[email protected] Keywords: COVID-19, ephedra, glycyrrhiza, network pharmacology, molecular docking Received: August 26, 2020 Accepted: November 30, 2020 Published: February 13, 2021 Copyright: © 2021 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Traditional Chinese medicine (TCM) had demonstrated effectiveness in the prevention and control of COVID-19.